enGene Therapeutics (ENGN) Earnings Date & Reports

enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ENGN is expected to report earnings to rise 5.42% to -45 cents per share on September 16

enGene Therapeutics ENGN Stock Earnings Reports

Q3'26

Est.

$-0.45

Q2'26

Beat

by $0.11

Q1'26

Beat

by $0.10

Q4'25

Missed

by $0.22

Q3'25

Missed

by $0.05

The last earnings report on June 15 showed earnings per share of -43 cents, beating the estimate of -54 cents. With 280.15K shares outstanding, the current market capitalization sits at 113.55M.

View a ticker or compare two or three

Compare

ENGN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ENGN